Skip to main content
Log in

The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes

  • Original Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Introduction

The purpose of this study was to develop the Japanese version of the Problem Areas in Diabetes (PAID) scale, a measure of emotional adjustment to diabetes that has been translated into Japanese by our group.

Materials and methods

A total of 418 Japanese people with diabetes attending our outpatient clinic participated (n = 65 type 1 and n = 353 type 2). We assessed the internal reliability of the PAID, examined correlations of the PAID with conceptually related psychosocial constructs, evaluated mean differences in the PAID between diabetes treatment groups, and examined correlations of the PAID with diabetes self-care behaviours and selected treatment outcomes.

Results

Results showed that the PAID had excellent reliability (Cronbach alpha = 0.934). The PAID correlated significantly with the Diabetes Treatment Satisfaction Questionnaire (r = −0.593, p < 0.0001) and the positive wellbeing (r = −0.396, p < 0.0001), negative wellbeing (r = −0.640, p < 0.0001) and energy (r = −0.444, p < 0.0001) subscales of the Wellbeing Questionnaire. Adherence to diet was negatively correlated with PAID score (r = −0.263, p < 0.0001). The frequency of recent hypoglycemia and number of chronic complications (retinopathy, nephropathy and neuropathy) were positively correlated with PAID scores. PAID was weakly correlated with HbA1c (r = 0.13, p = 0.01).

Conclusions

In conclusion, the Japanese version of the PAID demonstrated good internal reliability and evidence of concurrent and discriminant validity. The PAID measures the impact of diabetes, diabetes treatment and treatment outcomes on the emotions of people with diabetes. The results provide encouraging evidence for the clinical utility of the PAID in Japanese people with diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available, because they contain information that could compromise research participant privacy.

References

  1. Herschbach P, Duran G, Waadt S, Zettler A, Amm C, Marten-Mittag B. Psychometric properties of the Questionnaire on Stress in Patients with Diabetes-Revised (QSD-R). Health Psychol. 1997;16(2):171–4. https://doi.org/10.1037//0278-6133.16.2.171.

    Article  PubMed  CAS  Google Scholar 

  2. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6.

    Article  PubMed  CAS  Google Scholar 

  3. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31.

    Article  PubMed  Google Scholar 

  4. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000;23(3):273–7.

    Article  PubMed  CAS  Google Scholar 

  5. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23(9):1305–9.

    Article  PubMed  CAS  Google Scholar 

  6. Sigurdardottir AK, Benediktsson R. Reliability and validity of the Icelandic version of the Problem Area in Diabetes (PAID) Scale. Int J Nurs Stud. 2008;45(4):526–33. https://doi.org/10.1016/j.ijnurstu.2006.10.008.

    Article  PubMed  CAS  Google Scholar 

  7. Amsberg S, Wredling R, Lins PE, Adamson U, Johansson UB. The psychometric properties of the Swedish version of the Problem Areas in Diabetes Scale (Swe-PAID-20): scale development. Int J Nurs Stud. 2008;45(9):1319–28. https://doi.org/10.1016/j.ijnurstu.2007.09.010.

    Article  PubMed  Google Scholar 

  8. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.

    Article  PubMed  CAS  Google Scholar 

  9. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diabet Med. 2003;20(1):69–72.

    Article  PubMed  CAS  Google Scholar 

  10. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469–77. https://doi.org/10.1007/s00125-005-0094-2.

    Article  PubMed  CAS  Google Scholar 

  11. Bradley C. Diabetes treatment satisfaction questionnaire (DTSQ). In: Bradley C, editor. Handbook of psychology and diabetes. Chur: Harwood Academic Publ; 1994.

    Google Scholar 

  12. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990;7(5):445–51.

    Article  PubMed  CAS  Google Scholar 

  13. Riazi A, Bradley C, Barendse S, Ishii H. Development of the Well-being questionnaire short-form in Japanese: the W-BQ12. Health Qual Life Outcomes. 2006;4:40. https://doi.org/10.1186/1477-7525-4-40.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol. 1970;1:185–216.

    Article  Google Scholar 

  15. Carlson ED. A case study in translation methodology using the health-promotion lifestyle profile II. Public Health Nurs. 2000;17(1):61–70. https://doi.org/10.1046/j.1525-1446.2000.00061.x.

    Article  PubMed  CAS  Google Scholar 

  16. Marquis P, Keininger D, Acquadro C, Loge C. Translating and evaluating questionnaires: cultural issues for international research. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. Oxford: University Press; 2004. p. 78–93.

    Google Scholar 

  17. Hyrkas K, Appelqvist-Schmidlechner K, Oksa L. Validating an instrument for clinical supervision using an expert panel. Int J Nurs Stud. 2003;40(6):619–25. https://doi.org/10.1016/s0020-7489(03)00036-1.

    Article  PubMed  Google Scholar 

  18. Spector PE. Summated rating scale construction-an introduction. Newbury Park: Sage Publications, Inc.; 1992.

    Book  Google Scholar 

  19. Polit DF, Beck CT. Nursing research—principles and methods. Philadelphia: Lippincott Williams & Wilkins; 2004.

    Google Scholar 

  20. Belendez M, Hernandez-Mijares A, Marco J, Dominguez JR, Pomares FJ. Validation of the Spanish version of the Problem Areas in Diabetes (PAID-SP) Scale. Diabetes Res Clin Pract. 2014;106(3):e93–5. https://doi.org/10.1016/j.diabres.2014.09.012.

    Article  PubMed  Google Scholar 

  21. Huang MF, Courtney M, Edwards H, McDowell J. Validation of the Chinese version of the Problem Areas in Diabetes (PAID-C) scale. Diabetes Care. 2010;33(1):38–40.

    Article  PubMed  Google Scholar 

  22. Lygidakis C, Uwizihiwe JP, Bia M, Kallestrup P, Dukundane D, Asiimwe-Kateera B, et al. Cultural adaptation and psychometric evaluation of the Kinyarwanda version of the problem areas in diabetes (PAID) questionnaire. Health Qual Life Outcomes. 2021;19(1):183. https://doi.org/10.1186/s12955-021-01821-w.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ishii H, Bradley C, Riazi A, Barendse S, Yamamoto T. The Japanese Version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med. 2000;192(7):809–14.

    Google Scholar 

Download references

Acknowledgements

I would like to thank Prof. Alan Jacobson, Prof. Claire Bradley and Prof. William Polonsky for their very valuable advice on this study.

Funding

Funding to support this study was received from Eli Lilly Japan K.K

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuaki Hayashino.

Ethics declarations

Conflict of interest

YH has received honoraria from Novo Nordisk Pharma Ltd., Behringer Ingelheim Co., Ltd., and Sumitomo Pharma Co., Ltd.. HI has received honoraria from Eli Lilly Japan, Novo Nordisk Pharma Ltd., Merck & Co., Inc. and Sumitomo Pharma Co., Ltd. MG, TY, and ST declare no conflict of interest.

Ethical considerations

When the Japanese version of the PAID study was conducted, it was not common for research to be reviewed by an ethics committee, and studies were conducted without ethics committee approval. Shortly thereafter, it became necessary to obtain approval from an ethics committee to conduct clinical research. For this reason, we have been hesitant to submit the results of this study for publication. When we discussed this with the Ethics Committee of Tenri Hospital, we were told that if we applied to the Ethics Committee for approval as a study using data collected in the past, they would approve it, and so we decided to formally submit the paper as a paper. The study protocol, which conforms to the Declaration of Helsinki and the Ethical Guidelines for Clinical/Epidemiological Studies of the Japanese Ministry of Health, Labour and Welfare, received ethical approval from the Institutional Review Boards of Tenri Hospital on 14 December 2022 (No. 1326).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayashino, Y., Goto, M., Yamamoto, T. et al. The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes. Diabetol Int 15, 117–122 (2024). https://doi.org/10.1007/s13340-023-00661-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-023-00661-x

Keywords

Navigation